Carlyle Group Inc.
Institutional investor · Portfolio as of Q4 2021
Top Holdings8 positions
ATOTECH LTD | 153.7M | $3.9B | 40.8% | — | — | 4 qtrssince 2021-Q1 | Unchanged 0 |
ZOOMINFO TECHNOLOGIES INC | 44.3M | $2.8B | 29.5% | $50.72 | +27.62% | 7 qtrssince 2020-Q2 | Decreased 0 |
ORTHO CLINICAL DIAGNOSTICS H | 118.1M | $2.5B | 26.3% | — | — | 4 qtrssince 2021-Q1 | Unchanged 0 |
1Life Healthcare Inc | 13.6M | $239.2M | 2.5% | — | — | 8 qtrssince 2020-Q1 | Unchanged 0 |
VITRU LTD | 6.2M | $88.1M | 0.9% | — | — | 6 qtrssince 2020-Q3 | Unchanged 0 |
SEACOR MARINE HOLDINGS INC | 1.1M | $3.9M | 0.0% | $11.28 | -69.33% | 13 qtrssince 2018-Q4 | Unchanged 0 |
SIRIUSPOINT LTD | 129,408 | $1.1M | 0.0% | $10.29 | -20.89% | 4 qtrssince 2021-Q1 | Unchanged 0 |
| 7.9M | $0 | 0.0% | — | — | 13 qtrssince 2018-Q4 | Unchanged 0 |
Carlyle Group Inc. manages $9.6B across 8 positions as of Q4 2021. Top holdings: ATC (40.8%), GTM (29.5%), OCDX (26.3%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.
Exited 2, trimmed 1. No standout high-conviction moves this quarter. Portfolio: $9.6B across 8 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR